206 related articles for article (PubMed ID: 11374703)
1. Hyperfibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit.
Hu KQ; Yu AS; Tiyyagura L; Redeker AG; Reynolds TB
Am J Gastroenterol; 2001 May; 96(5):1581-6. PubMed ID: 11374703
[TBL] [Abstract][Full Text] [Related]
2. The efficacy and safety of epsilon-aminocaproic acid treatment in patients with cirrhosis and hyperfibrinolysis.
Gunawan B; Runyon B
Aliment Pharmacol Ther; 2006 Jan; 23(1):115-20. PubMed ID: 16393288
[TBL] [Abstract][Full Text] [Related]
3. Hyperfibrinolysis resulting from clotting activation in patients with different degrees of cirrhosis. The CALC Group. Coagulation Abnormalities in Liver Cirrhosis.
Violi F; Ferro D; Basili S; Quintarelli C; Musca A; Cordova C; Balsano F
Hepatology; 1993 Jan; 17(1):78-83. PubMed ID: 8423044
[TBL] [Abstract][Full Text] [Related]
4. Protein C and D-dimer are related to portal vein thrombosis in patients with liver cirrhosis.
Zhang D; Hao J; Yang N
J Gastroenterol Hepatol; 2010 Jan; 25(1):116-21. PubMed ID: 19686413
[TBL] [Abstract][Full Text] [Related]
5. Kinetic and functional studies of platelets, fibrinogen, and plasminogen in patients with hepatic cirrhosis.
Stein SF; Harker LA
J Lab Clin Med; 1982 Feb; 99(2):217-30. PubMed ID: 7061918
[TBL] [Abstract][Full Text] [Related]
6. Hemostatic abnormalities in chronic aggressive hepatitis and liver cirrhosis.
Ruggiero G; De Biasi R; Attanasio S; Bile G; Giusti G
Acta Hepatogastroenterol (Stuttg); 1975 Aug; 22(4):221-8. PubMed ID: 1179944
[TBL] [Abstract][Full Text] [Related]
7. [The relationship between hemostatic changes in liver cirrhosis patients with different degrees of liver lesions in reference to Child-Pugh scores].
Cong YL; Wei YX; Zhang LW; Yin ZJ; Bai J
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):31-4. PubMed ID: 15670488
[TBL] [Abstract][Full Text] [Related]
8. [Coagulation tests in septic surgical patients].
Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
[TBL] [Abstract][Full Text] [Related]
9. Association between high values of D-dimer and tissue-plasminogen activator activity and first gastrointestinal bleeding in cirrhotic patients. CALC Group.
Violl F; Basili S; Ferro D; Quintarelli C; Alessandril C; Cordova C
Thromb Haemost; 1996 Aug; 76(2):177-83. PubMed ID: 8865526
[TBL] [Abstract][Full Text] [Related]
10. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
11. Assessment of coagulation and fibrinolysis in children with chronic liver disease.
El-Sayed R; El-Karaksy H; El-Raziky M; El-Hawary M; El Koofy N; Helmy H; Fahmy M
Blood Coagul Fibrinolysis; 2013 Mar; 24(2):113-7. PubMed ID: 23314384
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of clotting and fibrinolytic systems in a follow-up of 165 liver cirrhotic patients. CALC Group.
Violi F; Ferro D; Basili S; Cimminiello C; Saliola M; Vezza E; Cordova C
Hepatology; 1995 Jul; 22(1):96-100. PubMed ID: 7601439
[TBL] [Abstract][Full Text] [Related]
13. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.
Maslow AD; Chaudrey A; Bert A; Schwartz C; Singh A
J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):6-15. PubMed ID: 18249324
[TBL] [Abstract][Full Text] [Related]
14. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
15. Quantitative assessment of fibrinogen cross-linking by epsilon aminocaproic acid in patients with end-stage liver disease.
Quach T; Tippens M; Szlam F; Van Dyke R; Levy JH; Csete M
Liver Transpl; 2004 Jan; 10(1):123-8. PubMed ID: 14755788
[TBL] [Abstract][Full Text] [Related]
16. Ascites fluid as a possible origin for hyperfibrinolysis in advanced liver disease.
Agarwal S; Joyner KA; Swaim MW
Am J Gastroenterol; 2000 Nov; 95(11):3218-24. PubMed ID: 11095345
[TBL] [Abstract][Full Text] [Related]
17. Importance of anticoagulant proteins in chronic liver diseases.
Gürsoy S; Başkol M; Torun E; Yurci A; Soyuer I; Eser B; Güven K; Ozbakir O; Yücesoy M
Turk J Gastroenterol; 2005 Sep; 16(3):129-33. PubMed ID: 16245221
[TBL] [Abstract][Full Text] [Related]
18. High-D-dimer plasma levels predict poor outcome in esophageal variceal bleeding.
Primignani M; Dell'Era A; Bucciarelli P; Bottasso B; Bajetta MT; de Franchis R; Cattaneo M
Dig Liver Dis; 2008 Nov; 40(11):874-81. PubMed ID: 18329968
[TBL] [Abstract][Full Text] [Related]
19. Haemostatic abnormalities in patients with liver disease associated with viral hepatitis.
Pramoolsinsap C; Busagorn N; Kurathong S
J Med Assoc Thai; 1996 Nov; 79(11):681-8. PubMed ID: 8997005
[TBL] [Abstract][Full Text] [Related]
20. Predictive factors of hyperfibrinolytic activity during liver transplantation in cirrhotic patients.
Steib A; Gengenwin N; Freys G; Boudjema K; Levy S; Otteni JC
Br J Anaesth; 1994 Nov; 73(5):645-8. PubMed ID: 7826793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
